IRCT20111206008307N41尚未招募3 期
Evaluation effect of empaglifulazin on depression in patients with heart failure with reduced ejection fraction: a randomizd clincal trial
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •Heart failure with reduced ejection fraction
- •Aged 18 to 80 years
- •Consented patients
排除标准
- •History of using empagliflozin
- •Kidney failure
- •Symptomatic hypotension
- •Systolic pressure below 100 or above 180 mm Hg
- •Contraindications of empagliflozin
- •Liver failure
研究者
相似试验
尚未招募
3 期
Ellagic acid in multiple sclerosisMultiple sclerosis.Multiple sclerosisIRCT20091114002709N54Iran University of Medical Sciences46
已完成
1 期
Empagliflozin in non alcoholic fatty liverDiabetic patient with non alcoholic fatty liver.Other specified inflammatory liver diseasesK75.8IRCT20150706023084N18Islamic Azad University30
招募中
2 期
Evaluation of the effect of empagliflozin on prevention of atrial fibrillation after heart surgeryAtrial fibrillation after heart surgery.Paroxysmal atrial fibrillationIRCT20120520009801N9Mashhad University of Medical Sciences160
尚未招募
3 期
The effect of empagliflozin on reduction of cardiovascular complication after PCIType 2 diabetes mellitus.Diabetes mellitus due to underlying conditionIRCT20210612051550N1Ahvaz University of Medical Sciences100
尚未招募
3 期
Evaluation of the effect of Empagliflozin on the severity of heart failure symptoms and echocardiography parameters in patients with congenital heart diseases with left-to-right shuntIRCT20120520009801N11Mashhad University of Medical Sciences44